Under the leadership of Kelly Piacsek, Ph.D., vice president of research, Rogers Behavioral Health is transforming the treatment and understanding of mental health, according to Dr. Brad Riemann, president of philanthropy, research and clinical care at Rogers.
“Because of Dr. Piacsek’s experience and passion for innovation, Rogers has been able to expand research to include groundbreaking, prospective studies aimed at accelerating its learning and delivering measurable improvements to mental health treatment practices,” Riemann said.
Piacsek is responsible for establishing the Rogers Research Center, which currently has 60 active studies, many of which involve national academic and clinical partners such as University of California-San Francisco, Harvard University and Baylor University.
The Research Center published 33 studies in 2022, on topics including the examination of symptoms of OCD and sleep disturbances, co-occurring OCD and PTSD, and telehealth.
“Rogers’ focus on evidence-based treatment protocols and quantitative patient-reported outcomes puts us in a unique position to do the kind of research that behavioral health has been lacking for a long time,” Piacsek said.
